[Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?].
Moosmann
Nicolas
N
Medizinische Klinik III , Universitätsklinikum München-Grosshadern, Marchioninistrasse 15, 81377 München. Nicolas.Moosmann@med.uni-muenchen.de
Boeck
Stefan
S
Heinemann
Volker
V
D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008207:Lymphatic Metastasis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D015996:Survival Rate